Skinmaxxing: the 'glass skin' routine, and where stacking actives backfires

Skinmaxxing — sometimes "dermmaxxing" — is the pursuit of flawless, poreless "glass skin" through an ever-expanding routine: cleanser, exfoliating acids, vitamin C, niacinamide, a retinoid, peptides, multiple serums and, correctly, sunscreen, often applied in a fixed nightly order copied from a forum or a video. The premise is that more active ingredients, more consistently layered, produce better skin. The dermatology evidence points the other way on almost everything except two ingredients — and it identifies the routine's own maximalism as a route to harm.

The honest summary is that skincare has a short list of things that genuinely change skin and a long tail of products that mostly change a bank balance. The two items with the strongest evidence are the two the trend treats as merely part of a longer stack.

The two ingredients that carry the evidence

The first is a retinoid. A systematic review of randomised trials of topical tretinoin for photoaging screened 180 studies and found seven that met its criteria; within those, the direction of effect was consistent across concentrations from 0.025% to 5% and durations from three to 24 months, with improvement in fine wrinkling and pigmentation and every trial reporting the drug as safe and well tolerated [s1]. A 2025 review places tretinoin's role across acne, photoaging and even skin-cancer chemoprevention on the same durable footing [s4]. That is a real effect from one molecule — and it is the reason our retinoids: over-the-counter versus prescription review concludes the prescription-strength version is where the evidence actually sits, not the weaker cosmetic "retinol" the routine usually substitutes.

The second is sunscreen, and it is the one step that has an outcome trial behind it rather than a surrogate-marker one. The evidence that regular sunscreen use reduces skin-cancer risk, and slows the photoaging the whole routine is chasing, is summarised in a CMAJ review of the trial and cohort data [s2]. Our sunscreen and skin-cancer evidence piece covers what daily use does and does not buy, and the piece on whether filters absorbed into blood matter addresses the safety question that circulates alongside it. In dermatology's own accounting, a retinoid at night and sunscreen in the morning outperform the twelve-step routine built around them.

Where stacking actives backfires

The trend's core assumption — that layering more actives compounds the benefit — is where it turns from wasteful to harmful. Retinoids and exfoliating acids both work partly by irritating and accelerating turnover of the skin, and the tretinoin literature is explicit that irritation is dose-dependent [s1][s4]. Piling a retinoid on top of glycolic or salicylic acid, a vitamin C at low pH, and a physical scrub — the maximal version of the routine — is a recipe for the "compromised barrier" that dermatologists increasingly see in young, heavy users: stinging, redness, peeling and a rebound of the very breakouts the routine was meant to fix. The American Academy of Dermatology's acne guideline is built on matching a small number of agents to the problem and introducing them carefully, not on maximal concurrent use [s3].

Over-exfoliation is the specific failure mode. There is no evidence that exfoliating harder or more often improves skin, and good mechanistic reason to expect the opposite once the barrier is stripped. "Glass skin" as marketed is largely lighting, youth and genetics; chasing it with a heavier active load past the point of irritation makes skin worse, not more optimised.

The parts with little behind them

Most of the remaining steps are cosmetically pleasant and evidentially thin. At-home LED masks are a good example of a device with a plausible mechanism and modest, uneven trial support rather than the transformation the marketing implies — our at-home LED devices for acne review sets out how far that evidence goes. Oral "skin" supplements — collagen, biotin, assorted botanicals — are a particularly weak link: the meta-analytic evidence for supplements against photoaging is limited and dominated by industry-funded studies with soft endpoints, as our skin-supplement meta-analysis piece details. And the dietary claims folded into skinmaxxing are more mixed than the confident forum advice suggests, which our acne and diet evidence review unpacks.

What to watch

Skinmaxxing is not dangerous the way some optimisation trends are, but its logic is inverted. The evidence rewards restraint — one retinoid, one sunscreen, introduced slowly — and penalises the maximalism the name celebrates. A routine that leaves skin stinging, red or breaking out is not under-optimised; it is over-treated, and the fix is subtraction. Persistent or severe acne, and any changing or suspicious mole, are reasons to see a clinician rather than to add another serum.

Sources

• [s1] Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials — International Journal of Women's Dermatology, 25 March 2022. https://doi.org/10.1097/jw9.0000000000000003
• [s2] The efficacy and safety of sunscreen use for the prevention of skin cancer — CMAJ, 13 December 2020. https://doi.org/10.1503/cmaj.201085
• [s3] Guidelines of care for the management of acne vulgaris — Journal of the American Academy of Dermatology, 30 January 2024. https://doi.org/10.1016/j.jaad.2023.12.017
• [s4] An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer — Journal of Clinical Medicine, 10 November 2025. https://doi.org/10.3390/jcm14227958